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Introduction 
Asphyxia is due to impaired delivery of oxygen to organs and
cells. The syndrome of perinatal asphyxia in foals is usually a
consequence of a combination of ischaemia and hypoxaemia.
The syndrome may cause a wide variety of clinical abnormalities
depending on the degree, the duration, and the target organ of
the insult. Two categories of PAS have been described.
Category 1 consists of foals that have a normal delivery, with
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PAS can cause a wide variety of clinical abnormalities, of which seizures due to
encephalopathy are the most significant. The structural and biochemical components of
CNS neurones are disrupted by the shift from oxidative to anaerobic metabolism, with a
resultant deficit in cellular energy. The cells succumb to the combined effects of
acidosis, neurotoxic activities of glutamate, nitric oxide and free radicals, lipid
peroxidation, accumulation of intracellular calcium and destructive overactivity of
intracellular enzymes. Concurrently, the hypoxia affects other organ systems and
management of foals presenting with CNS signs requires the veterinarian to undertake a
thorough clinical examination and to institute appropriate therapy for the various
derangements induced by the hypoxic-ischaemic episode. Diazepam (0.1 to 0.2mg/kg
bwt) can be used for short-term control of seizures; phenobarbital (2 to 10mg/kg bwt)
may be required for more prolonged treatment of recurrent seizures. The needs of the
affected foal for nutrients, fluids and electrolytes, antimicrobial therapy and ancillary
therapies were discussed in the literature review and illustrated in the case report.
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Products used in the treatment of perinatal asphyxia in the foal.
Product Trade name Manufacturer
Diazepam Valium Roche
Gentamicin Gentaject Franklin Pharmaceuticals
Ceftiofur Excenel Pharmacia and upjohn
Ketoprofen Ketofen 10% Merial animal health
Allopurinol Allopurinol Non-proprietary
Vitamin E Vitenium Novartis animal health
Polyionic fluids Isolec Ivex UK
Parenteral nutrition Clinomel  Baxters
Phenobarbital Phenobarbital Non-propriety
Omeprazole losec Astra UK
Magnesium sulphate Mag sul 25% Arnolds
DMSO VWR International UK
Triple lumen catheter Mila International USA
Indwelling stomach tube Mila International USA
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normal post-natal behaviour; the onset of clinical signs is likely to
be within 24 hours of birth. Category 2 foals have an abnormal
birth and are weak and possibly recumbent from birth; these
foals have a much poorer prognosis (Hess-Dudar and Rossdale,
1996a). Foals that are suffering from the CNS disturbances of
PAS have been referred to as “dummies”, “barkers”, or
“wanderers”. The term ‘neonatal maladjustment syndrome’ is
commonly used to describe the condition; however, perinatal
asphyxia syndrome (PAS) is a more accurate term. 
Predisposing factors 
The principal causes of hypoxia in the foetus and neonate are
listed in Table 1. Maternal factors that contribute to perinatal
asphyxia are those that cause hypotension or reduced tissue
oxygenation. Placental pathology will impair uteroplacental
perfusion. Areas of chronic placental separations may lead to
chronic hypoxia of the foetus. The most acute cause of perinatal
asphyxia is complete premature placental separation at birth (red
bag delivery). Twinning will lead to reduced area of
placentation available for perfusion to each foetus and, also, will
predispose to dystocia and its associated complications:
compression of the umbilical cord, placental separation, and
aspiration of meconium. Factors that lead to decreased tissue
oxygenation and blood flow in the neonate include sepsis,
prematurity and dysmaturity (Furr, 1996).
Pathogenesis 
Hypoxic-ischaemic insults affect many organs. The CNS may
suffer the most profound damage: inadequate supplies of oxygen
and glucose trigger a cascade of interrelated changes as the
neurones react to the deficient supply of energy (Volpe, 1995).
There is massive release of glutamate (leading to a large influx of
calcium ions), increased production of free radicals, diminished
ability of the sodium pumps, altered distribution of ions (large
quantities of sodium, chloride and calcium enter the neurones,
while potassium leaks out). The new ionic gradients draw water
into the neurones and within the swollen cell the excess calcium
overactivates many enzyme systems that damage vital cell
constituents and kill the neurones, also damaged by oxygen-free
radicals that initiate the peroxidation of phospholipids in their
cell membranes (Westbrook, 1993; Volpe, 1995).
Clinical findings 
Clinical signs vary depending on the degree and the duration of
the asphyxia and on the system most affected by the insult. CNS
signs can be very variable depending on the degree of hypoxia.
Mild hypoxia may manifest with signs as subtle as the foal being
‘hyperexcitable’ (Vaala, 2002). Other symptoms may include
generalised weakness, lack of interest in the mare, lack of suck
reflex, apparent blindness, walking into the mare, walking into
walls, recumbency and seizures (Hess-Dudan and Rossdale,
1996a,b). Where there is severe CNS depression and coma
there will be loss of central regulation of respiration,
temperature and blood pressure, leading ultimately to death
(Vaala, 2002).
Gastrointestinal manifestations of PAS may include ileus,
colic, retained meconium, necrotising enterocolitis, and
gastric ulceration. Adverse effects on the cardiovascular
system include reduced myocardial contractility, decreased
cardiac output, and systemic hypotension; these effects, in
turn, can increase the hypoxic insult to other systems.
Asphyxia can damage the respiratory centre in the brain.
The lungs are vulnerable to secondary atelectasis because
the decrease in pulmonary perfusion impairs the delivery of
the substrates that the pneumocytes require for the
production of surfactant. Damage to renal tubular cells may
be seen clinically as decreased urine output. Hepatic and
endocrine systems may be involved; however, there is not
much literature on these effects in neonatal foals (Furr,
1996).
While abnormalities of one organ system may predominate
it is important to evaluate all other systems, and determine
the degree of involvement.
TABLE 1: Factors that may lead to the perinatal asphyxia
syndrome in foals
Maternal Respiratory disease
Endotoxaemia
Haemorrhage/anaemia
Surgery/caesarean delivery
Placental Placentitis (bacterial, fungal, endophyte)
Chronic uteroplacental separation
Acute/premature uteroplacental separation (red bag 
delivery)
Foetal Twinning
Congenital abnormalities
Dystocia
Aspiration of meconium
Sepsis
Prematurity
Dysmaturity
When lying,diarrhoeic foals need to be maintained in sternal recumbency
and turned frequently to avoid pressure sores.
 Vet•Dec04•cat's edits  11/22/04  12:19 PM  Page 708Volume 57 (12) : December,2004
Irish Veterinary Journal
709
peer reviewed
Differential diagnosis 
Differential diagnosis of seizures in neonatal foals (Vaala, 2002)
includes:
(i)  metabolic disorders (hypocalcaemia, hypomagnesaemia, 
hypo/hyperglycaemia, hypo/hypernatraemia, azotaemia 
and hepatoencephalopathy), 
(ii) infectious conditions (meningitis, septicaemia and equine 
herpesvirus infection), 
(iii) trauma to cranium or spinal column, 
(iv) congenital abnormalities (hydrocephalus, 
occipitalatlantoaxial malformations), 
(v) toxins. 
Once these differentials can be ruled out, perinatal asphyxia
must be considered as a cause of the neurological deficits.
Clinical pathology 
There are no pathognomonic clinicopathological changes for
PAS. Most often, haematology is normal but when concurrent
sepsis is present there may be leucopaenia or leukocytosis;
importantly, even in sepsis the haemogram may remain
unchanged. In moderate to severe asphyxia there may be
acidosis with a pH less than 7.3 and bicarbonate concentration
less than 20mmol/L. Respiratory depression will lead to
hypoxaemia (PaO2 <60mmHg) and hypercapnoea (PaCO2
>65mmHg).
Substantial elevations in creatine kinase may correlate with a
hypoxic-ischaemic insult to the neonate in utero or during the
birth; however, it may also be an indicator of muscle trauma
either at birth or after (Madigan, 1997). Increases in plasma
creatinine concentrations in the first 24 hours of life can occur
in neonates in the absence of renal disease; most likely it is an
indicator of adverse maternal and/or placental conditions and
will reduce over the following days. However, if it remains
elevated then renal dysfunction must be considered. 
Treatment 
Supportive therapy 
The immediate environment of a convulsing or hyperexcitable
foal should be as quiet and dark as possible to minimise the
effects of outside stimuli. Recumbent foals need to be kept
warm and dry, maintained in sternal recumbency and turned
frequently to avoid pressure sores.
Anticonvulsive therapy 
Seizures result in increased demand for oxygen in brain and
muscle tissues, further adding to the hypoxic insult. The aim of
seizure control is to prevent further damage to the CNS and to
reduce the risk of trauma to the neonate. 
Diazepam (0.1 to 0.2mg/kg bwt) when administered i.v. has a
rapid action but its effects are of short duration. Phenobarbital
is necessary to control severe seizures; the dose (2 to 10mg/kg
bwt q12h) must be given slowly i.v. to avoid respiratory
depression. Abrupt cessation of phenobarbital therapy may
result in resumption of seizures; therefore, it may be prudent to
gradually decrease the dosages over 24 to 48 hours (Furr,
1996). 
Nutritional support 
A neonatal foal should receive 10% of its body weight in milk
each day; if the foal is not sucking, this should be divided into
hourly feeds administered via indwelling stomach tube. If there
are clinical signs of gastrointestinal dysfunction (colic, ileus,
diarrhoea), total enteral feeding is unlikely to be tolerated. The
parenteral route can be used as the sole source of nutrition or it
may be used to top-up a decreased enteral intake.
Complications associated with parentral nutrition include
problems with the intravenous catheter, hypokalaemia,
hyperlipaemia and hyperglycaemia. Withdrawn of parenteral
nutrition must be done gradually over 24 hours.
Fluid and electrolyte therapy 
Overzealous fluid administration is contraindicated in animals
suffering from ischaemic encephalopathy, as it may increase
cerebral oedema. However, maintenance requirements must be
met. Monitoring packed cell volume and total protein
concentration are not very accurate in determining the fluid
status in the neonate: they have very broad ranges and they may
not increase until the foal is severely dehydrated. The volume of
parentral nutrition must be taken into account when calculating
total maintenance volume. Maintenance requirements would be
5 to 6ml/kg bwt/h of a balanced polyionic fluid (Hartmann’s).
There is evidence to suggest that isotonic sodium replacement
fluids are not suitable for maintenance in critically ill foals.
Buchanan et al. (2003) reported that healthy foals lost weight
and their serum sodium concentrations and osmolality increased
when they were given a 24h infusion of an isotonic sodium-
containing fluid. Hypokalaemia secondary to hyperglycaemia
may be seen during the use of parenteral nutrition; when that
happens, potassium supplementation is necessary. Intravenous
plasma may be required if passive transfer of immunoglobulins
has been inadequate.
Non-invasive blood pressure monitoring, together with data on
Foals with category 1 form of perinatal asphyxia syndrome have normal
delivery and normal postnatal behaviour but develop symptoms within 24
hours of birth.
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clinical hydration and urine output, may be the most accurate
way of determining fluid status in neonates (Corley, 2002 a,b).
Normal urine production in a suckling foal is 6ml/kg bwt/h
(Brewer et al., 1990). However, in the critically ill foal receiving
i.v. infusions, it is the fluid balance (the difference between the
volume of all fluids taken in and the volume of urine) that is
important; this should be small and represent insensible, faecal
and homeostatic fluid loss. Early intervention to restore
circulating volume and tissue perfusion is necessary if urine
output falls below 66% of all fluids delivered.
The specific gravity of the urine can be measured, the normal
being 1.001 to 1.009. Dehydration or hypovolaemia will usually
result in much higher specific gravity readings (Corley, 2002a).
Antimicrobial therapy 
Antimicrobials have an important role in treatment and
prophylaxis of infection in PAS foals. Recumbent foals are at
high risk of infection; negative blood culture and normal
haemograms may not be enough to rule out ongoing sepsis.
Concurrent sepsis or development of secondary sepsis are poor
prognostic indicators.
Respiratory support 
Most PAS foals will benefit from intranasal administration of
humidified oxygen. Blood gases provide a useful indication of
the oxygen status of the foal while recumbent. Maintaining foals
in sternal recumbency has been shown to increase PaO2 (Furr,
1996).
Periods of apnoea, either secondary to phenobarbital
administration or following hypoxic damage to the respiratory
centre, can be treated with caffeine, which is the safest of the
methylxanthines. However, overdosing can cause increased
CNS, myocardial and gastrointestinal stimulation. In cases of
severe respiratory depression, mechanical ventilation may be
required. 
Specific treatments 
The following drugs have been used in the treatment of
perinatal asphyxia in foals. 
Dimethylsulphoxide (DMSO)
DMSO (1g/kg bwt i.v. q24 hrs) is a scavenger of free radicals
and may reduce further inflammation in the cerebrum. It is
administered in a solution at no greater than 20% concentration,
as higher concentrations can cause haemolysis. Alternatively, it
can be administered via nasogastric tube.
Vitamin E
Vitamin E, a major antioxidant in the lipid environment,
reduces the amount of lipid peroxidation in affected organs. As
it is lipid soluble, it may take two to three days to reach
therapeutic levels. Therefore, ideally, it needs to be given pre-
insult, to maximise its effect (Tan and Parks, 1999).
Vitamin C 
Vitamin C (ascorbic acid), a major antioxidant in the aqueous
environment, is one of the principal antioxidants in the foetus
(Tan and Parks, 1999); it is thought to have a neuroprotective
effect.
Thiamine 
Administered at 10 to 20mg/kg bwt i.v. q12h, it may have a
role in preventing the glutamate-induced cell death (Vaala,
2002).
Magnesium sulphate 
Magnesium is an NMDA (N-methyl-D-aspartate) receptor
antagonist. NMDA mediates the influx of calcium into the cell
and in perinatal asphyxia an excess accumulation of intracellular
calcium is responsible for the death of neurones. Human studies
have shown that magnesium is effective only when given pre-
insult (Tan and Parks, 1999). However, in one study (Wilkins,
2001) magnesium sulphate infusions were thought to reduce
seizures in neonatal foals. Infusion rates were 50mg/kg bwt/h
for the first hour as a loading dose, then reduced to 25mg/kg
bwt/h as a constant-rate infusion.
Allopurinol 
The main property of this drug is as a xanthine oxidase
inhibitor. In hypoxia-reoxygenation or ischaemic-reperfusion
injuries xanthine oxidase reacts with purine breakdown products
to produce oxidants. Allopurinol has been shown to be effective
post-insult in hypoxic-ischaemic human neonates (Tan and
Parks, 1999). 
Outcome 
Vaala (2002) reported a survival rate of 70% to 80% in foals
suffering from uncomplicated PAS. The prognosis is poorer in
foals that develop concurrent sepsis, fail to show clinical
improvement in five days, or experience serious seizures. 
Future performance is not necessarily compromised in foals that
survive without significant complications.
Recognition of risk factors 
It is important to recognise risk factors and events and to
anticipate the occurrence of perinatal asphyxia. Foals at risk
include those born to mares that have previously delivered a
PAS foal, had placental abnormalities, had difficult deliveries, or
had a systemical illness or surgery during the current gestation.
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Case report
History 
A Thoroughbred colt foal, 24-hour-old and weighing 50kg, was
referred to the hospital with a history of acute onset seizure-like
activity one hour previously. The foal had been born
uneventfully to a pluriparous mare that had not had any
problems with her previous foals nor had she shown any signs of
illness during the recent 341-day pregnancy. The placenta was
examined and found to be normal. The colt had exhibited
normal activity after birth: he stood within 40 minutes, suckled
the mare one hour after foaling, passed meconium without any
problem. At 14 hours of age the concentration of
immunoglobulin G was >800mg/dl. 
The foal was discovered at 24 hours of age lying in the stable
exhibiting violent galloping-like activity and he could not be
aroused. He was given 10mg diazepam intravenously
(0.2mg/kg bwt) almost immediately by the referring
veterinarian.
Clinical examination 
On admission, one hour after the onset of clinical signs, the foal
was recumbent, exhibiting extensor rigidity of all four limbs,
opisthotonous and nystagmus. Assessment of physical
parameters revealed a temperature of 100.4ºC, heart rate of
104 beats per minute, respiratory rate of 40 breaths per minute
with normal auscultation and slightly reduced gut motility.
There was no evidence of trauma to the foal, either primary or
secondary to the seizures.
Clinical pathology 
Initial haematology was unremarkable (Table 2). There was
mild azotaemia, elevated concentration of creatine kinase, and
mild hypoglycaemia (most likely due to reduced enteral intake).
Cerebrospinal fluid evaluation was within normal limits: white
blood cell count 2.2 x10
9/L (reference range: less than
5x10
9/L; Furr and Bender, 1994) and total protein 1.6g/L
(reference range: 0.4 to 1.7g/L; Rossdale et al., 1982). Culture
of blood taken on admission yielded a negative result.
Treatment 
The immediate aim of treatment was to prevent and to control
any further seizures. Once the initial clinical assessment was
performed, 10mg of diazepam (0.2mg/kg bwt) was
administered intravenously (i.v.). This caused immediate muscle
relaxation and reduced excitability; 20 minutes later a further
10mg diazepam was given i.v. Humidified oxygen was
administered via nasal insufflation at a flow rate of 5 L/minute. 
An intravenous triple-lumen catheter (Mila International, Inc.,
Florence, Kentucky 42041, USA) was inserted into the right
jugular vein: separate ports were used for administration of
parenteral nutrition and for crystalloids; the third port was used
TABLE 2: Clinical pathological findings in a Thoroughbred colt foal with perinatal asphyxia syndrome
Admission  Day 2  Day 3 Day 4 Reference range
White blood cells x10
9/L 9.3 15.6 11.0 9.7 3.7 -  12.1
Haematocrit L/L 0.32 28.7 29.4 28.3 0.31 - 0.45
Neutrophils x10
9/L 6.6 9.5 6.2 6.3 1.7   - 10.1
Lymphocytes x10
9/L 2.5 5.3 4.7 3.0 0.5 - 2.9
Fibrinogen g/L 2.0 2.5 3.0 3.0 1.7 - 3.2
Total protein g/L 52 54 54 50 42 - 59
Albumin g/L 28 26 28 26 26 - 34
Globulin g/L 24 28 26 24 12 - 31
Immunoglobulin G mg/dl >800 > 800
AST iu/L 187 181 175 155 111 - 206
Creatine kinase iu/L 1258 856 354 288 165 - 761
Blood urea nitrogen mmol/L 5.54 3.78 4.4 4.6 2.9 - 8.4
Creatinine µmol/L 230 168 126 134 97 -  188
GGT iu/L 29 28 32 29 10 - 32
Bilirubin (total) µmol/L 43 67 52 54 16 - 94
Sodium mmol/L 140 142 144 142 134 - 144
Potassium mmol/L 3.9 2.9 3.2 3.9 3.8 - 4.8
Chloride mmol/L 104 100 99 101 99 -  104
Glucose mmol/L 3.1 7.7 11.5 9.4 4.8 - 9.9
AST: aspartate aminotransferase; GGT: gamma glutamyl transferase.
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for drug delivery. Crystalloid fluid therapy (polyionic fluids with
supplemented glucose to make a 5% glucose solution) was
administered at 10ml/kg bwt/h for the first hour; then,
maintenance polyionic fluids (without glucose) were continued
at 5ml/kg bwt/h. Parenteral nutrition was initiated with a
commercially available mixture (Clinomel, Baxter), which
provided 1kcal/ml. Infusion was started at 30kcal/kg bwt/day
and was gradually increased to 40kcal/kg bwt/day over the
next 12h. One hour after admission the glucose concentration
had risen to 5.4mmol/L and further measurements, taken every
four hours, were within an acceptable range (4.8 to
9.9mmol/L). 
A single treatment of 300mg allopurinol (6mg/kg bwt) was
administered via stomach tube.
Further treatments consisted of 50g (1g/kg bwt) of dimethyl
sulphoxide (DMSO) i.v. as a 5% solution q24h for five days (this
was incorporated into the overall fluid requirements of the foal),
200mg vitamin E (4mg/kg bwt)/ 2mg selenium (0.04mg/kg
bwt) i.m. q24h for five days, 1g magnesium sulphate (20mg/kg
bwt) i.v. q24h for five days, 100mg ketoprofen (2mg/kg bwt)
i.v. q24h for five days. Empirical antibiotic therapy was initiated:
250mg ceftiofur (5mg/kg bwt) i.v. q.i.d. and 330mg
gentamicin (6.6mg/kg bwt) i.v. q24h was introduced on day 2,
once the azotaemia had been controlled. Omeprazole (1mg/kg
bwt) i.v. q24h was used as prophylactic therapy for gastric
ulceration.
The foal was kept in a dark and very quiet environment to
minimise the effects of external stimuli. He was maintained in
sternal recumbency to aid ventilation and perfusion of the
lungs, and was turned every two hours to prevent pressure
sores. An indwelling urinary catheter was inserted and
connected to a closed urine collection system. 
There was no seizure over the following two hours but
diazepam (0.2mg/kg bwt i.v.) did not control seizure-like
activity that occurred after that interval and 500mg
phenobarbital (10mg/kg bwt) was administered i.v. in 30ml of
saline over 20 minutes. This regime was repeated every eight
hours and any evidence of mild seizure breakthrough in-
between these treatments was treated with 5mg diazepam
(0.1mg/kg bwt) i.v. 
During the 12 hours following presentation, there was no
evidence of respiratory depression and abdominal auscultation
revealed normal borborygmi. An indwelling 10Fr (radioopaque)
nasogastric tube (Mila International, Inc., Florence, Kentucky
42041, USA) was inserted and enteral feeding was initiated.
Small volumes of mare’s milk (50ml/h) were fed and this was
tolerated very well, there was no reflux at any time, and this
volume was increased to 100ml/h over the next 24h. 
Urine production was monitored closely, and hourly rates and
specific gravity were recorded. In the first 24h, urine was
produced at the rate of 140ml/kg bwt/day and specific gravity
was within normal limits (1.001 to 1.009). Total infusates
(enteral and i.v.) in the first 24 h were roughly 8.5L; thus, the
ouput of urine during that interval was approximately 80% of
the fluid delivered. During the following three days urine
production rates varied from 72% to 86% of fluid delivered.
On day 2 of hospitalisation, the foal had intermittent mild
seizure activity despite the continued phenobarbital therapy
(10mg/kg bwt i.v. t.i.d.). Enteral and parentral nutrition were
continued. Maintenace intravenous fluids were continued at
3ml/kg bwt/h. Potassium chloride (20mmol/L) was added to
i.v. fluids, to correct the hypokalaemia (Table 2). A leukocytosis
was present with neutrophilia and lymphocytosis; creatinine had
returned to normal values and creatine kinase was reducing
(Table 2). One litre of a commercial hyperimmunised plasma
was administered over three hours. Intravenous omeprazole
therapy was discontinued and replaced by oral omeprazole
50mg (1mg/kg bwt) q24h. Nasal oxygen therapy was
continued at 5L/minute. Clinical examination was
unremarkable, respiratory rate remained stable, and abdominal
auscultation revealed consistent normal gut motility. Milk-based
normal faeces were being passed. There was no gastric reflux.
On the morning of day 3, the phenobarbital dose was reduced
to 8mg/kg bwt i.v. t.i.d. Enteral (100ml/h) and parenteral
(40kcal/kg bwt/day) nutrition was continued. Maintenance
intravenous fluid therapy (3ml/kg bwt/h) was supplemented
with potassium chloride (20mmol/L), as a mild hypokalaemia
persisted. White blood cell count and creatine kinase
concentration had returned to normal. There was a mild
hyperglycemia for a short period during day 3 (Table 2).
Oxygen therapy was continued at 5L/minute. During the
following eight hours there was one episode of extensor rigidity
and opisthotonus, which responded to 5mg diazepam
(0.1mg/kg bwt) i.v. Auscultation of the lungs at this time
revealed increasingly harsh inspiratory and expiratory noises.
Ultrasonography showed bilateral mild pleural thickenings with
small areas of consolidation (<0.3cm) on the surface of the
lungs. Twice daily nebulisation with 80mg gentamicin
(1.6mg/kg bwt) was initiated.
On the morning of day 4, phenobarbital treatment was reduced
to 5mg/kg bwt i.v. During the following eight hours the foal
became more alert, without evidence of hyperexcitation.
Intravenous phenobarbital was discontinued and 100mg oral
phenobarbital (2mg/kg bwt q12h) was administered p.o. on
the evening of day 4. Enteral nutrition was increased to 150ml
mare’s milk every hour, parenteral nutrition was reduced to
30kcal/kg bwt/day. Maintenance fluid therapy, supplemented
with 20mmol potassium chloride per litre, was continued at
3ml/kg bwt/h. Clinical pathology on day 4 was unremarkable
(Table 2).
On the morning of day 5, the foal was assisted to stand for a
few minutes each hour. The urinary collection system was
removed. The foal exhibited an increasing interest in the mare;
however, he did not have a suck reflex. Feeding by indwelling
nasogastric tube continued and was increased to 200ml/h.
Parenteral nutrition was decreased to 15kcal/kg bwt/day.
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Maintenance fluid therapy was decreased to 2ml/kg bwt/h.
When he stood, the foal urinated normally, with exteriorised
penis; there was mild urinary tenesmus, most likely due to
urethritis, a sequel to catheterisation. Normal to soft milk-based
faeces were being passed. Clinical pathology did not show any
abnormalities on day 5. Phenobarbital therapy was discontinued
on the evening of day 5.
On day 6, the foal stood unassisted and the suck reflex started
to return; however, he had no interest in sucking the mare.
Enteral nutrition was increased to 250ml/h via the indwelling
stomach tube. Parenteral nutrition was withdrawn during day 6.
Fluid therapy was continued at 3ml/kg bwt/h. DMSO, vitamin
E, magnesium and ketoprofen therapies were discontinued at
this stage. Clinical pathology was unremarkable. Fluid therapy
was reduced to 2ml/kg bwt/day.
On day 7, the foal was assisted to nurse from the mare and
nasogastric feeding and fluid therapy were reduced as the
amount of suckling increased during the following 12h. The
indwelling stomach tube was removed on the morning of day 8.
Auscultation and ultrasonography of the lungs showed a
satisfactory improvement in the condition of the lung and
nebulisation was discontinued on the evening of day 8, as were
fluid and oxygen therapies. 
The foal continued to make excellent clinical progress and he
was discharged from the hospital on day 12. Antibiotic therapy
(5mg ceftiofur/kg bwt i.m. q12h) and omeprazole (1mg/kg
bwt p.o. q24h) were continued for a further seven days. Over
the following year, the foal had no health problems.
Discussion 
This foal would be assigned to category one as described by
Hess-Dudan and Rossdale (1996a). He had a normal birth with
normal postnatal activity, but the clinical symptoms of PAS
started at 24h of age. 
After initial anticonvulsive therapy and stabilisation, the next
step was to investigate the cause of the seizures. The differential
diagnoses mentioned by Vaala (2002) had to be considered.
There was no evidence of external trauma or of congenital
anomalies. CSF analysis was within normal limits, as were serum
electrolyte concentrations at the time of admission. On the
bases of these observations and the clinical signs, a diagnosis of
PAS was made.
There was a mild increase in plasma creatinine concentration,
which was most likely a reflection of prepartum placental
insufficiency; this was within normal limits by day 2. The
elevated creatine kinase may correlate with a hypoxic-ischaemic
insult to the foetus while in utero or at birth (Madigan, 1997);
however, it may also be an indicator of muscle trauma either at
birth or after. 
Septicaemia is a frequent sequel to perinatal asphyxia; therefore,
although the leukogram was normal and the blood culture was
negative when the foal was admitted, antimicrobials were added
to the treatment regime.
The foal showed no evidence of gastrointestinal dysfunction
(reflux, ileus); enteral feeding via indwelling stomach tube was
tolerated, in progressively increasing amounts. Partial parenteral
nutrition was introduced in the first 24 hours and withdrawn
gradually once enteral intake increased. Complications from
parenteral nutrition that we experienced were the hypokalaemia
on day 2, and mild transient hyperglycaemia on day 3.
Administration of polyionic fluid supplemented with 20mmol
potassium chloride/L helped to restore the serum potassium
concentration to normal.
Close monitoring of all organ systems is important and allows
early aggressive intervention, if necessary. Monitoring urine
production and specific gravity gave an indication of the
cardiovascular status of the foal. As there were no ongoing
losses due to diarrhoea or gastric reflux, maintenance
requirements would be 5 to 6ml/kg bwt/h of a balanced
polyionic fluid. 
This foal was maintained on intranasal humidified oxygen from
admission until day 8. Blood gases were not measured; that
would have provided a useful indication of the oxygen status of
the foal while recumbent and would have given us information
regarding any secondary hypoxaemia as a result of the lung
pathology noted on day 3. 
This case shows the need for multisystemic therapy in foals
suffering from PAS. Cardiovascular, electrolyte, respiratory and
nutritional supports were instigated in addition to
anticonvulsive therapy and therapies aimed specifically at the
ongoing pathophysiology.
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